Get started
Author

Lutz van Heek

Observed names: L van Heek, L. van Heek, Lutz Van Heek, Lutz van-Heek, Van Heek, Lutz, van Heek, Lutz
OpenAlex ID: A5085719322
Influences on PET Quantification and Interpretation
2022 · Julian M. M. Rogasch, Frank Hofheinz, et al. · Diagnostics · 50
PDF
Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
2020 · Conrad-Amadeus Voltin, Jasmin Mettler, et al. · Clinical Cancer Research · 47
PDF
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
2023 · Simone Wegen, Katrin Sabine Roth, et al. · Clinical Nuclear Medicine · 41
Head-to-Head Comparison of [68 Ga]Ga-FAPI-46-PET/CT and [18F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
2022 · Simone Wegen, Lutz van Heek, et al. · Molecular Imaging and Biology · 41
PDF
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial
2022 · Lutz van Heek, Colin Stuka, et al. · Nuklearmedizin - NuclearMedicine · 40
PDF
Dual-tracer PET/CT protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
2022 · Katrin S Roth, Conrad-Amadeus Voltin, et al. · Journal of Nuclear Medicine · 28
PDF
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach
2021 · Philipp Linde, Christian Baues, et al. · Cancer Imaging · 26
PDF
Dual-tracer PET/CT protocol with [18F]FDG and [68Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [18F]FDG in different cancer types, resulting in larger functional and gross tumor volume
2023 · Simone Wegen, Jasmin Weindler, et al. · Strahlentherapie und Onkologie · 21
PDF
PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study
2021 · D.A. Eichenauer, S. Kreissl, et al. · Annals of Oncology · 20
PDF
Prognostic value of baseline metabolic tumor volume ( MTV ) for forecasting chemotherapy outcome in early‐stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial
2023 · Lutz van Heek, Jasmin Weindler, et al. · European Journal Of Haematology · 17
Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases
2018 · Jochen Hammes, Lutz van Heek, et al. · EJNMMI Physics · 17
PDF
PET/CT Reconstruction and Its Impact on [Measures of] Metabolic Tumor Volume
2023 · Henry Knaup, Jasmin Weindler, et al. · Academic Radiology · 9
PDF
Metabolic Tumor Volume after Two Cycles of Chemotherapy in Patients Treated for Advanced-Stage Hodgkin Lymphoma: Analysis of the German Hodgkin Study Group Phase III HD18 and HD21 Trials
2024 · Justin Ferdinandus, Helen Kaul, et al. · Blood · 7
PDF
Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin’s lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group
2023 · Justin Ferdinandus, Lutz van Heek, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 4
PDF
Avoidance of iodine deficiency/excess during pregnancy in Hashimoto’s thyroiditis
2021 · Lutz van Heek, Christiane Staudacher, et al. · Nuklearmedizin - NuclearMedicine · 4
P024: Predictive Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial
2022 · Lutz Van Heek, Colin Stuka, et al. · HemaSphere · 1
Metabolisches Tumorvolumen nach zwei Zyklen Chemotherapie bei Patienten mit Hodgkin-Lymphom im fortgeschrittenen Stadium: Analyse der Phase-III-Studien HD18 und HD21 der Deutschen Hodgkin Studiengruppe
2025 · K S Roth, H Kaul, et al. · Nuklearmedizin - NuclearMedicine
PET/CT reconstruction and its impact on Metabolic Tumor Volume
2023 · H. T. Knaup, J. Weindler, et al. · Nuklearmedizin - NuclearMedicine
PET-based response assessment in Hodgkin lymphoma patients undergoing PD-1 blockade: data of the German Hodgkin Study Group NIVAHL trial for early unfavorable stages
2021 · C Voltin, J Mettler, et al. · Nuklearmedizin - NuclearMedicine
Works count: 22
Citation count: 373
H-index: 11
I10-index: 11
Year
Topic
Type